CBIO

•

Equity

GLOBAL X CHINA BIOTECH UCITS ETF

TER (bps):

68

AUM (USD m):

2

ISIN:

IE0004LIBFM2

Domicile:

Ireland

Share Class Currency:

USD

ESG:

No

Geographical Focus:

China

As of:

28 Nov 2023

Climate Fund:

No

Benchmark

The Solactive China Biotech v2 Index measures performance of companies involved in the development of biotechnology in China, including companies whose principal business is in research, development, manufacturing, and distribution of new drugs, therapies, or vaccines using biological materials.

PERFORMANCE

Powered byhttps://www.etfbook.com/ logo

RELATED ARTICLES

Statue of bull after the Shenzen Exchange in China
Industry Updates

China and precious metal ETFs disappoint in Q2

The big re-opening has underwhelmed

Theo Andrew

Nuclear power station
New Listing

Global X launches uranium ETF

Tracking around 50 companies in the uranium industry

Theo Andrew

MOST READ

1
Industry Updates

ETF Stream reveals winners of ETF awards 2023

ETF Stream

2
Industry Updates

DWS to offer Europe’s cheapest gold ETC after fee cut

Theo Andrew

3
Analysis

Larger ETFs are not always more liquid

Tom Eckett

4
Analysis

ETF fee war returns to Europe

Jamie Gordon

5
Industry Updates

DWS slashes fees on 31 ETFs

Theo Andrew